OSR Holdings Inc (OSRH) - Total Assets
Based on the latest financial reports, OSR Holdings Inc (OSRH) holds total assets worth $177.29 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See OSRH book value for net asset value and shareholders' equity analysis.
OSR Holdings Inc - Total Assets Trend (2020–2024)
This chart illustrates how OSR Holdings Inc's total assets have evolved over time, based on quarterly financial data.
OSR Holdings Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
OSR Holdings Inc's total assets of $177.29 Million consist of 19.8% current assets and 80.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.9% |
| Accounts Receivable | $300.00K | 13.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how OSR Holdings Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see OSR Holdings Inc (OSRH) total market value.
Key Asset Composition Facts
- Current vs. Non-Current Assets: OSR Holdings Inc's current assets represent 19.8% of total assets in 2024, an increase from 19.4% in 2020.
- Cash Position: Cash and equivalents constituted 2.9% of total assets in 2024, down from 19.4% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 13.0% of total assets.
OSR Holdings Inc Competitors by Total Assets
Key competitors of OSR Holdings Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Argen-X
F:1AE
|
Germany | €7.18 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.93 Billion |
|
BrightGene Bio Medical Technology C
SHG:688166
|
China | CN¥5.38 Billion |
|
Dashenlin Pharm Grp Co Ltd
SHG:603233
|
China | CN¥26.08 Billion |
|
Staidson Beijing Biopharma
SHE:300204
|
China | CN¥1.26 Billion |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287
|
China | CN¥6.64 Billion |
|
Ardelyx Inc
NASDAQ:ARDX
|
USA | $486.17 Million |
|
Xiangxue Pharmaceutical
SHE:300147
|
China | CN¥7.36 Billion |
OSR Holdings Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.21 | 0.01 | 0.01 |
| Quick Ratio | 0.20 | 0.01 | 0.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-11.83 Million | $-3.90 Million | $-702.45K |
OSR Holdings Inc - Advanced Valuation Insights
This section examines the relationship between OSR Holdings Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.16 |
| Latest Market Cap to Assets Ratio | 5.53 |
| Asset Growth Rate (YoY) | -93.7% |
| Total Assets | $2.30 Million |
| Market Capitalization | $12.73 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values OSR Holdings Inc's assets at a significant premium (5.53x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: OSR Holdings Inc's assets decreased by 93.7% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for OSR Holdings Inc (2020–2024)
The table below shows the annual total assets of OSR Holdings Inc from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $2.30 Million | -93.71% |
| 2023-12-31 | $36.63 Million | +2887.94% |
| 2022-12-31 | $1.23 Million | +73.86% |
| 2021-12-31 | $705.09K | +118.46% |
| 2020-12-31 | $322.75K | -- |
About OSR Holdings Inc
OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatme… Read more